NIDDK Central Repository - Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents.

An official website of the United States government

NIDDK Central Repository

Publication Information

DOI

10.1016/j.jhep.2010.01.028

PubMed ID

20400194

Public Release Type

Journal

Publication Year

2010

Affiliation

Université Catholique de Louvain, Cliniques universitaires St Luc, Bruxelles, Belgium. etienne.sokal@uclouvain.be

Authors

Bourgois A, Fischler B, Gardovska D, Kelly D, Porta G, Silveira T, Sokal EM, Stéphenne X

Studies

PEDS-C

Citation

Sokal EM, Bourgois A, Stéphenne X, Silveira T, Porta G, Gardovska D, Fischler B, Kelly D. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents. J Hepatol 2010 Jun;52(6):827-31. Epub 2010 Mar 15.

Abstract

This multi-center study aimed to prospectively evaluate the safety and efficacy of a genotype-based Pegylated Interferon alfa-2a/Ribavirin therapy in treatment-naïve hepatitis C virus (HCV), positive HCV serology, and quantifiable HCV RNA, infected children.